Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Allergan logo

Allergan will start phase III DARPin trials next year

Will investigate drug in wet age-related macular degeneration

- PMLiVE

UK innovation prize to support antibiotic diagnostics

Longitude Prize 2014 offers £10m to develop tool to fight antimicrobial resistance

- PMLiVE

JPA strengthens PR offering

Three new employees join the agency’s London office

- PMLiVE

Merck & Co extends med ed portal to India

Pharma company makes Univadis accessible to yet more healthcare professionals

Healthcare marketing compliance in the UK – prevention beats cure

UK's MHRA gives its views on rep training, pharma advertising and social media

- PMLiVE

Introducing pharma perspectives

Matt de Gruchy outlines the HCC's forthcoming collaboration with PME

- PMLiVE

Lundbeck’s desmoteplase flunks phase III stroke trial

No better than placebo at improving disability symptoms

Novartis building

Novartis pulls EMA application for expanded Tasigna use

And Boehringer confirms it won't seek approval for faldaprevir as it exits hepatitis C

- PMLiVE

Third time lucky as MannKind’s inhaled insulin is approved

US FDA backs new diabetes treatment Afrezza

- PMLiVE

Comms agencies “intend to do right” by Wikipedia

Ogilvy & Mather, FleishmanHillard, Weber Shandwick and more sign statement on online encyclopaedia

Astellas adds to US comms team

Marty Golden appointed VP, government affairs

- PMLiVE

Biosimilar Lantus leads CHMP opinions

Boehringer and Lilly’s insulin one of six new medicines recommended for EU approval

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links